№ files_lp_4_process_3_093328
File format: docx
Character count: 1631
File size: 13 KB
Structured clinical outline summarizing the planned treatment approach for a patient diagnosed with schizophrenia.
Year:
2026
Region / City:
Not specified
Subject:
Mental Health / Psychiatry
Document Type:
Clinical Treatment Outline
Institution / Organization:
Not specified
Author:
Not specified
Target Audience:
Mental health professionals
Period of Application:
Initial and ongoing treatment phase
Diagnosis:
F20.9 Schizophrenia
Treatment Goals:
Social, relational, occupational improvement
Assessment Requirements:
Initial clinical assessments as needed
Therapist Characteristics:
Empathy, consistency, reliability
Treatment Location:
Facility-based or therapist’s office depending on patient needs
Interventions:
Role-playing, exposure exercises, individual therapy sessions
Treatment Emphasis:
Interpersonal and occupational skills
Treatment Nature:
Individual therapy, possible family involvement
Frequency and Duration:
Weekly sessions for 6–12 months
Medications:
Antipsychotics as prescribed
Adjunct Services:
Occupational therapy, medical monitoring
Prognosis:
Recovery defined by functional and social improvements; outcome depends on therapeutic relationship and adherence
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Type of document:
Pharmaceutical Benefits Advisory Committee (PBAC) submission and assessment report
Medicine:
Aripiprazole long-acting injectable (AOM)
Dosage forms/strengths:
Powder for injection 300 mg (as monohydrate) with diluent in pre-filled dual-chamber syringe; Powder for injection 400 mg (as monohydrate) with diluent in pre-filled dual-chamber syringe
Brand:
Abilify Maintena
Sponsor:
Lundbeck Australia Pty Ltd
Purpose of submission:
Request for General Schedule Authority Required (STREAMLINED) PBS listing of AOM pre-filled syringe dose form
Indication:
Treatment of schizophrenia
Comparator:
AOM modified release injection vial kit (therapeutic vial kits)
Regulatory status:
TGA registered 7 May 2018 for acute and maintenance treatment of schizophrenia in adults and maintenance treatment of bipolar I disorder (monotherapy)
Previous PBAC consideration:
400 mg AOM PFS recommended July 2018; recommendation rescinded March 2023
Pricing basis:
Cost-minimisation versus AOM vial kit with equivalent pricing (no price premium)
Price levels referenced:
DPMQ, PTP, AEMP (current as of 1 June 2025)
Estimated PBS usage:
400,000 to <500,000 scripts over first six years (Year 1 10,000–<20,000; Year 6 100,457)
Indication listing conditions:
Authority Required (Streamlined); prescriber types include medical practitioners and nurse practitioners; general schedule (Code GE)
Year:
2023
Region / city:
Rohtak, Haryana
Topic:
Schizophrenia, Psychiatric Rehabilitation
Document Type:
Research Article
Organization / Institution:
Institute of Mental Health, Pt. B.D. Sharma University of Health Sciences, PGIMS
Author:
Dr. Aakanksha Kharb, Dr. Nandini Lamba, Dr. Pradeep Kumar
Target Audience:
Mental Health Professionals, Researchers, Medical Students
Period of Action:
Ongoing
Approval Date:
Not specified
Date of Changes:
Not specified
Version:
2.1
Executive Lead:
Executive Director of Quality and Medical Leadership
Lead Author:
Principal Clinical Pharmacist
Approved Date:
14/11/2022
Approved By:
Drugs and Therapeutics Committee (DTC)
Ratified Date:
14/11/2022
Ratified By:
Drugs and Therapeutics Committee (DTC)
Issue Date:
08/02/2023
Expiry Date:
14/11/2025
Target Audience:
Clinical staff
Document Type:
Guidelines
Ratifying Committee:
Drugs and Therapeutics Committee (DTC)
Review Date:
14/11/2025
Summary of significant changes from previous version:
Minor amendments: References to Xeplion® LAI in the document changed to Paliperidone monthly LAI as generic version available
Purpose:
Provide clinical staff with clear guidance on prescribing antipsychotics for the management of psychosis / schizophrenia in adults.
Date:
10 October 2014
Event:
World Mental Health Day
Theme:
Living with schizophrenia
Institution:
University of Cape Town
Department:
Department of Psychiatry and Mental Health, University of Cape Town
Issued by:
UCT Communication and Marketing Department
Media Liaison Officer:
Kemantha Govender
Location:
Rosebank, South Africa
Research Focus:
Genetic and neuroscientific studies on schizophrenia
Population Studied:
Xhosa population of South Africa
Type of Document:
Press release
Contact Information:
Tel (021) 650 5672; Cell (084) 737 6522; [email protected]
Note:
Year
Theme:
Mental Health / Schizophrenia / Text Messaging
Document Type:
Moderator’s Guide
Author:
Michele
Target Audience:
People with Schizophrenia, Mental Health Professionals
Context:
A moderator’s guide for gathering feedback from individuals with schizophrenia on the effectiveness of text messaging for relapse prevention and symptom monitoring.
Year:
2023
Region / City:
Nanjing, Jiangsu Province, China
Topic:
Neuroscience, Psychiatry, Schizophrenia, Bipolar Disorder
Document Type:
Research Article
Organization / Institution:
Affiliated Brain Hospital of Nanjing Medical University
Author:
Yilin Tang, Ruiqiu Zhu, Yucheng Ling, Yifan Wang, Yingbo Dong, Peiyu Cao, Yuting Li, Qi Si, Guoxin Xu, Zhuma Jin, Yuxiu Sui
Target Audience:
Psychiatry researchers, neuroscientists, medical professionals
Period of Activity:
2023
Date of Approval:
2023
Date of Changes:
Not specified
Keywords:
Schizophrenia, Bipolar disorder, Psychosis symptoms, MRI, Basal ganglia
Abstract:
This study investigates the volume changes of basal ganglia subregions in patients with schizophrenia (SCZ), bipolar disorder (BD), and healthy controls (HC), with a focus on the relationship between these changes and psychotic symptoms.
Species accumulation curve and diversity indices comparison between schizophrenia and control groups
Year:
2026
Region / city:
Not specified
Subject:
Schizophrenia, Metabolomics
Document type:
Research figure and table
Organization / institution:
Not specified
Author:
Not specified
Target audience:
Researchers in schizophrenia and metabolomics
Period of validity:
Not specified
Approval date:
Not specified
Date of changes:
Not specified
Year:
Not specified
Region / City:
Not specified
Topic:
Neurological Disorders, Psychiatry, Neuroimaging
Document Type:
Scientific Supplementary Figure
Organization / Institution:
Not specified
Author:
Not specified
Target Audience:
Researchers, Clinicians
Period of Validity:
Not specified
Approval Date:
Not specified
Date of Changes:
Not specified
Contextual Description:
A scientific supplement detailing post-hoc comparisons of FAT and FW between healthy controls, adolescent-onset schizophrenia, and adolescent-onset bipolar disorder with psychosis, using neuroimaging data.
Year:
2023
Region / City:
Global
Topic:
Mental Health, Psychosis, Schizophrenia
Document Type:
Research Protocol / Search Strategy
Organization:
N/A
Author:
N/A
Target Audience:
Researchers, Mental Health Professionals
Effective Period:
N/A
Approval Date:
N/A
Revision Date:
N/A
Keywords:
psychosis, schizophrenia, risk, treatment, early intervention, qualitative research, search strategy
Year:
2001
Region / City:
United States
Theme:
Mental health, biography, film study
Document Type:
Educational assignment / discussion guide
Institution:
High school / college classroom
Author:
Not specified
Target Audience:
Students studying psychology or film
Related Work:
Film "A Beautiful Mind" directed by Ron Howard
Topics Covered:
Schizophrenia, biography, character analysis, treatment methods, critical thinking
Date Assigned:
Not specified
Due Date:
Friday (as mentioned in text)
Note:
Year
Contextual description:
A scientific paper presenting supplementary methods related to polygenic analysis and causal inference in the relationship between loneliness, isolation, and schizophrenia.
Year:
2018
Region / Institution:
National University of Ireland Galway, Ireland
Subject:
Cognitive training, schizophrenia, neuroimaging
Document type:
Systematic review and meta-analysis
Authors:
David Mothersill, Gary Donohoe
Corresponding author:
Gary Donohoe, Professor of Psychology, School of Psychology, National University of Ireland Galway
Number of studies reviewed:
31
Neuroimaging methods:
fMRI, SPECT, PET, cortical thickness, VBM, DTI
Key findings:
Increased left prefrontal activation, distributed neural effects
Keywords:
neuroimaging; cognitive remediation therapy; psychosis; prefrontal
Word count abstract:
225
Word count main text:
3,007
Figures:
2
Tables:
2
Supplemental information:
1
Time period covered:
studies published until December 2018
Note:
Year
Year:
2022
Region / City:
RBKC
Subject:
Asset Management, Housing Maintenance
Document Type:
Tender Briefing
Organization:
RBKC Housing Management
Author:
Not specified
Target Audience:
Service Providers
Period of Validity:
Not specified
Approval Date:
May 2022
Date of Revisions:
Not specified
Year:
Not provided
Region / City:
Not provided
Subject:
Application form for radiation-emitting equipment and user monitoring
Document Type:
Form
Organization:
TÜV Rheinland Philippines, Inc.
Author:
Not provided
Target Audience:
Facility administrators and staff handling radiation-emitting equipment
Period of Validity:
Not provided
Approval Date:
Not provided
Amendment Date:
Not provided
Organization:
Lindgren Tax & Accounting, Inc.
Address:
11515 Lake Lane Boulevard, Suite 102, Chisago City, MN 55013
Country:
United States
Document type:
Client information notice
Tax year referenced:
2025
Office hours period:
February 2, 2026 – April 15, 2026
Offseason hours period:
After April 15, 2026
Contact methods:
Secure client portal, email, in-person drop-off
Tax professionals:
Cory Lindgren; Wade Clarin
Service delivery format:
In-person drop-off, secure digital submission, mailed hard copy
Confidentiality policy:
No transmission of confidential documents via email or text
Additional fees:
$10 hard copy mailing fee
Staff changes:
Departure of Courtney Knuth after 2025 season
Applicable jurisdiction:
U.S. federal income tax
Referenced legislation:
Permanent tax rate and deduction changes effective for 2025
Target audience:
Existing tax clients of Lindgren Tax & Accounting, Inc.
Year:
2025
Region / city:
Washington State
Subject:
Client overpayment procedures, forms, and submission process
Document type:
Policy & Procedure Bulletin
Organization:
Department of Social and Health Services (DSHS), Home and Community Services Division (HCS), Developmental Disabilities Community Services Division (DDCS)
Author:
Catherine Kinnaman, Kris Pederson
Target audience:
Home and Community Services Division Regional Administrators, Developmental Disabilities Community Services Regional Administrators, Area Agency on Aging Directors
Period of validity:
From December 24, 2025
Approval date:
December 24, 2025
Date of changes:
December 2025
Year:
2023
Region / City:
Asia Pacific
Theme:
Legal Research, Client Referral, Law Firm Ranking
Document Type:
Submission Form
Organization / Institution:
The Legal 500
Author:
The Legal 500 Research Team
Target Audience:
Law Firms
Period of Validity:
Ongoing
Approval Date:
8/3/2021
Date of Last Update:
2023
Year:
2023
Region / City:
New Zealand
Topic:
Client assessment, support needs, rehabilitation
Document type:
Referral form
Organization / Institution:
ACC (Accident Compensation Corporation)
Author:
Not specified
Target audience:
ACC staff, healthcare providers, assessors
Period of validity:
Not specified
Approval date:
Not specified
Modification date:
Not specified